14-a
| phenoxyacetic acid derivative | 3.7 | nd | 3.6 | nd |
15 |
N-desmethyl glucuronide | 1.6 | nd | 1.5 | nd |
16 |
N-despyridinyl | 1.2 | nd | 1.0 | nd |
24-a
|
N-desmethyl glucuronide | 1.8 | nd | 2.1 | nd |
34-a
|
ortho-O-glucuronide | 0.3 | nd | 0.2 | nd |
4 |
N-desmethyl-para-O-sulfate | 17.7 | nd | 18.4 | nd |
5 |
para-O-glucuronide | 3.8 | nd | 3.4 | nd |
6 |
N-desmethyl-ortho-O-sulfate | 0.7 | nd | 1.0 | nd |
9 |
N-desmethyl-ortho-hydroxy (SB 243914) | 1.1 | 0.7 | 1.0 | 0.2 |
7 |
N-desmethyl-para-hydroxy | nd | 6.1 | nd | 6.9 |
8 |
ortho-O-sulfate | 3.5 | nd | 3.3 | nd |
174-a
| unknown | 0.3 | nd | 0.3 | nd |
10 |
para-O-sulfate | 15.9 | nd | 17.5 | nd |
11 |
ortho-hydroxy (SB 244675) | 0.1 | 0 | 0.2 | 0.2 |
12 |
N-desmethyl (SB 237216) | 0.5 | nd | 0.2 | nd |
13 |
para-hydroxy | 0.1 | 9.0 | 0.1 | 10.8 |
144-a
| rosiglitazone | 0.1 | nd | 0.0 | nd |
|
Total assigned 0–8 day (urine) or 0–7 day (fecal extracts)4-b
| 52.3 | 15.8 | 53.7 | 18.0 |
| | (46.1) | | (47.5) |
0–8 day urinary or 0–7 day fecal excretion | 55.3 | 17.7 | 56.9 | 20.5 |
Percentage of 0–8 day urinary or 0–7 day fecal excretion assigned | 94.6 | 88.9 | 94.5 | 87.5 |
| | (83.4)4-b
| | (83.5)4-b
|
Total urinary or fecal excretion 0–21 day | 62.3 | 21.6 | 66.3 | 25.2 |
Percentage of 0–21 day urinary or fecal excretion assigned | 84.2 | 73.1 | 81.2 | 71.3 |
| | (74.0)4-b
| | (71.6)4-b
|